7'-Bromo-1H,1'H-[2,3']biindolylidene-3,2'-dione 3-[O-(2-piperazin-1-yl-ethyl)-oxime]

ID: ALA4080255

Chembl Id: CHEMBL4080255

PubChem CID: 135423833

Max Phase: Preclinical

Molecular Formula: C22H24BrCl2N5O2

Molecular Weight: 468.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.Cl.O=C1Nc2c(Br)cccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1

Standard InChI:  InChI=1S/C22H22BrN5O2.2ClH/c23-16-6-3-5-15-18(22(29)26-19(15)16)21-20(14-4-1-2-7-17(14)25-21)27-30-13-12-28-10-8-24-9-11-28;;/h1-7,24-25H,8-13H2,(H,26,29);2*1H/b21-18-,27-20+;;

Standard InChI Key:  JXVVUJJCDZDPLO-CRNVARIRSA-N

Associated Targets(Human)

KCL-22 (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MeWo (235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.36Molecular Weight (Monoisotopic): 467.0957AlogP: 2.86#Rotatable Bonds: 4
Polar Surface Area: 77.99Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.19CX Basic pKa: 9.17CX LogP: 2.14CX LogD: 0.62
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.37Np Likeness Score: -0.36

References

1. Gaboriaud-Kolar N, Myrianthopoulos V, Vougogiannopoulou K, Gerolymatos P, Horne DA, Jove R, Mikros E, Nam S, Skaltsounis AL..  (2016)  Natural-Based Indirubins Display Potent Cytotoxicity toward Wild-Type and T315I-Resistant Leukemia Cell Lines.,  79  (10): [PMID:27726390] [10.1021/acs.jnatprod.6b00285]
2. Wang H, Wang Z, Wei C, Wang J, Xu Y, Bai G, Yao Q, Zhang L, Chen Y..  (2021)  Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship.,  223  [PMID:34161865] [10.1016/j.ejmech.2021.113652]

Source